While CD133+ progenitor cells isolated from renal tumors are not tumorigenic by themselves, they can enhance tumor development and angiogenesis when co-transplanted with malignant cells, indicating their contribution to cancer progression. This evidence concerns the gene PROM1 and neoplasm.